Trifluoroacetic acid → HCID 12300190, compound
Reaction equation
[OH:1][C:2]([C@@H:4]1[CH:19]=[C:18]2[C@@H:8]([CH2:9][C:10]3[C:20]4[C:13](=[CH:14][CH:15]=[CH:16][C:17]2=4)[NH:12][CH:11]=3)[N:6]([CH3:7])[CH2:5]1)=[O:3].C(O)(C(F)(F)F)=O.[Br:28]Br>O1CCOCC1.C(Cl)(Cl)Cl>[Br:28][C:11]1[NH:12][C:13]2[C:20]3[C:10]=1[CH2:9][C@@H:8]1[C:18](=[CH:19][C@@H:4]([C:2]([OH:1])=[O:3])[CH2:5][N:6]1[CH3:7])[C:17]=3[CH:16]=[CH:15][CH:14]=2Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 5 °C
Procedure
Lysergic acid (8.05 g, 30 mmol) is suspended in dioxane and is treated with dropwise addition of TFA (exothermic). Bromine (1.54 ml, 30 mmol, 1.0 eq.) in chloroform is added dropwise. The reaction is cooled to 5° C. and product crystallizes. (6aR,9R)-5-Bromo-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid is isolated by filtration and re-crystallised from diethylether. Rf=0.5, 10% MeOH:DCM, M+H+=346, 348, m.p.>245 (decomposition).
Workup
- customproduct crystallizes
Sources & evidence
- ORD record
- ord-1efb07e85d18488ab72754eb8a2e7391
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07666877B2
Reaction notes
Loading…